SO
AKBA icon

STRS Ohio’s Akebia Therapeutics AKBA Stock Holding History

STRS Ohio’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-285,500
Closed -$204K – 2037
2022
Q1 		$204K Hold
285,500
– – ﹤0.01% 1705
2021
Q4 		$645K Hold
285,500
– – ﹤0.01% 1392
2021
Q3 		$822K Buy
285,500
+55,700
+24% +$159K ﹤0.01% 1235
2021
Q2 		$870K Buy
229,800
+11,400
+5% +$38.4K ﹤0.01% 1253
2021
Q1 		$739K Hold
218,400
– – ﹤0.01% 1385
2020
Q4 		$611K Hold
218,400
– – ﹤0.01% 1369
2020
Q3 		$548K Buy
218,400
+148,500
+212% +$1.3M ﹤0.01% 1277
2020
Q2 		$949K Buy
69,900
+62,900
+899% +$651K ﹤0.01% 912
2020
Q1 		$53K Buy
+7,000
New +$54.5K ﹤0.01% 1775
2019
Q4 		– Sell
-47,800
Closed -$187K – 2054
2019
Q3 		$187K Hold
47,800
– – ﹤0.01% 1663
2019
Q2 		$231K Buy
47,800
+2,700
+6% +$15.4K ﹤0.01% 1666
2019
Q1 		$369K Buy
45,100
+2,300
+5% +$15.8K ﹤0.01% 1456
2018
Q4 		$236K Buy
42,800
+17,700
+71% +$139K ﹤0.01% 1599
2018
Q3 		$221K Sell
25,100
-1,500
-6% -$13.4K ﹤0.01% 1695
2018
Q2 		$265K Sell
26,600
-25,100
-49% -$251K ﹤0.01% 1663
2018
Q1 		$492K Hold
51,700
– – ﹤0.01% 1324
2017
Q4 		$768K Buy
51,700
+5,700
+12% +$94.5K ﹤0.01% 1034
2017
Q3 		$904K Hold
46,000
– – ﹤0.01% 923
2017
Q2 		$661K Buy
+46,000
New +$583K ﹤0.01% 1170
2015
Q1 		– Sell
-2,700
Closed -$28.7K – 1804
2014
Q4 		$31K Hold
2,700
– – ﹤0.01% 1658
2014
Q3 		$60K Buy
+2,700
New +$62K ﹤0.01% 1625

Other funds holding AKBA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

STRS Ohio's AKBA Position: Q2 2022 in Review

STRS Ohio sold out of Akebia Therapeutics (AKBA) in Q2 2022, closing a stake of 285,500 shares — an estimated $204K sold.

STRS Ohio first reported a position in AKBA in Q3 2014 and held it in 21 quarters. The position peaked at $949K in Q2 2020. 96 funds tracked by Wall St. Rank hold AKBA as of Q2 2022.

  • STRS Ohio reported no remaining Akebia Therapeutics position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 285,500 Akebia Therapeutics shares in Q2 2022, an estimated $204K.
  • STRS Ohio first reported a position in Akebia Therapeutics in Q3 2014 and held it in 21 quarters.
  • STRS Ohio's Akebia Therapeutics position peaked at $949K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.